Mexico Confirms Case of New World Screwworm in Nuevo Leon
On Sept. 21, 2025, Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) confirmed a new case…
-
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA Announces Plan to Combat New World Screwworm’s Northward Spread
On Jun. 18, 2025, the U.S. Department of Agriculture announced it has launched an $8.5 million sterile New…
-
Colorado Department of Public Health Reported Second Potential Measles Case Identified
On Apr. 7, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | Vaccine | Veterinary | WHO
Mexico confirms country’s first human case of bird flu in 3-year-old girl
On Apr. 4, 2025, a 3-year-old girl from the western state of Durango is Mexico’s first confirmed human…
-
CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Colorado Department of Public Health Reported Additional Measles Exposure Locations
On Apr. 2, 2025, the Colorado Department of Public Health and Environment issued a Health Alert Network (HAN)…
-
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
-
Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
-
Sorrento announced full enrollment of phase I study of intranasal STI-9199 (COVISHIELD) against Omicron BA.2 and all variants of concern
On May 2, 2022, Sorrento announced its Phase I study of intranasal STI-919 OVISHIELDTM) had been fully enrolled…
-
Swissmedic granted conditional Marketing Authorization for Novavax COVID-19 vaccine
On Apr. 13, 2022, Novavax announced that Swissmedic had granted Novavax conditional marketing authorization (CMA) for Nuvaxovid COVID-19…
-
Biotechnology | COVID-19 | FDA | Therapeutics
Sorrento announced FDA authorization to proceed with phase 1 study of Intranasal STI-9199 against Covid-19 viruses
On Mar. 2, 2022, Sorrento Therapeutics announced that its Phase I study of intranasal (IN) STI-9199 (COVISHIELDTM IN) has…
-
Scientists found genetic link to clogged arteries
On Mar. 24, 2021, scientists from Washington University School of Medicine in St. Louis announced they had identified…
-
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
-
T2 Biosystems announced worldwide licensing agreement of COVID-19, novel Coronavirus assay
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
-
The CDC responded to a Hantavirus outbreak in the southwestern U.S.
On May 14, 1993, the New Mexico Department of Health (NMDOH) reported it was notified by the Office…
-
Korean Hemerologic fever was isolated near Hantan river in South Korea
In 1978, the etiologic agent of Korean Hemerologic fever was isolated from small infected field rodent Apodemus agrarius…
